Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

• Joyce V. Lee,
• Filomena Housley,
• Christina Yau,
• Rachel Nakagawa,
• Juliane Winkler,
• Johanna M. Anttila,
• Pauliina M. Munne,
• Mariel Savelius,
• Kathleen E. Houlahan,
• Daniel Van de Mark,
• Golzar Hemmati,
• Grace A. Hernandez,
• Yibing Zhang,
• Susan Samson,
• Carole Baas,
• Marleen Kok,
• Laura J. Esserman,
• Laura J. van ‘t Veer,
• Hope S. Rugo,
• Christina Curtis,
• Juha Klefström,
• Mehrdad Matloubian,
• Andrei Goga

Affiliations

Joyce V. Lee

Department of Cell and Tissue Biology, University of California

Filomena Housley

Department of Cell and Tissue Biology, University of California

Christina Yau

Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging

Rachel Nakagawa

Department of Cell and Tissue Biology, University of California

Juliane Winkler

Department of Cell and Tissue Biology, University of California

Johanna M. Anttila

Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki

Pauliina M. Munne

Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki

Mariel Savelius

Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki

Kathleen E. Houlahan

Stanford Cancer Institute, Stanford University School of Medicine

Daniel Van de Mark

Department of Cell and Tissue Biology, University of California

Golzar Hemmati

Department of Cell and Tissue Biology, University of California

Grace A. Hernandez

Department of Cell and Tissue Biology, University of California

Yibing Zhang

Department of Cell and Tissue Biology, University of California

Susan Samson

Helen Diller Family Comprehensive Cancer Center, University of California

Carole Baas

Alamo Breast Cancer Foundation

Marleen Kok

Department of Medical Oncology, Netherlands Cancer Institute

Laura J. Esserman

Helen Diller Family Comprehensive Cancer Center, University of California

Laura J. van ‘t Veer

Helen Diller Family Comprehensive Cancer Center, University of California

Hope S. Rugo

Helen Diller Family Comprehensive Cancer Center, University of California

Christina Curtis

Stanford Cancer Institute, Stanford University School of Medicine

Juha Klefström

Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki

Mehrdad Matloubian

Department of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California

Andrei Goga

Department of Cell and Tissue Biology, University of California